Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXHIA trial of dexamethasone phosphate via sacro-coccygeal hiatus for refractory lumbosciatica
2021-001571-17Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of dexamethasone sodium phosphate in Sciatica, sciatic neuropathy and lumbodynia (LBP), sponsored by CHU de Nantes. Primary endpoint: Oswestry Disability Index change at 3 weeks. Started May 2021; status: completed.
02
Drugs
dexamethasone sodium phosphate
03
Conditions
Sciaticasciatic neuropathylumbodynia (LBP)
Beyond the preview
Go deeper on 2021-001571-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001571-17.